Safinamide Mesylate

CHEMBL48582 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

398.5 g/mol

LogP

—

Phase

4

A mesylate salt form of safinamide with the same therapeutic properties. Taken as an add-on to levodopa therapy, this medication helps smooth out the motor fluctuations that Parkinson's patients experience as their levodopa dose wears off.

Masse moléculaire

398,5000 g/mol

TPSA

127,00 Å²

Aires thérapeutiques

Parkinson's Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)O.C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O

InChI

InChI=1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1

Molecular Formula

C18H23FN2O5S

HBD / HBA

3 / 7

Liaisons Rotatives

7

Atomes Lourds

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A mesylate salt form of safinamide with the same therapeutic properties. Taken as an add-on to levodopa therapy, this medication helps smooth out the motor fluctuations that Parkinson's patients experience as their levodopa dose wears off.

Yes, Safinamide Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL48582. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3038502. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Safinamide Mesylate sur PillFYI

Structure

Données Clés

Formule: C18H23FN2O5S
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.